Clinical Trials
22 trialsStem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
National Institutes of Health Clinical Center (CC)
ALT-101
Allterum Therapeutics, Inc
Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
Laguna Biotherapeutics, Inc.
Weight Gain in Pediatric Leukemia Survivors
Washington University School of Medicine
Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.
Arovella Therapeutics Ltd
ThINKK-01
St. Justine's Hospital
SOUNDTRACK-C1
AstraZeneca
CHIS
Assistance Publique - Hôpitaux de Paris
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
The Children's Hospital of Zhejiang University School of Medicine
ACITAC-001
Instituto Distrital de Ciencia, BiotecnologÃa e Innovación en Salud - IDCBIS
QOL-ONE PRO-CT
Associazione Qol-one
CASEY
Baylor College of Medicine
ALL Backbone in AYAs
Dana-Farber Cancer Institute
A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies
Biotroy Therapeutics
HEM-iSMART E
Princess Maxima Center for Pediatric Oncology
succinylation
The First Affiliated Hospital of Xinxiang Medical College
SEVENAZA
Gustave Roussy, Cancer Campus, Grand Paris
PACMAN
Princess Maxima Center for Pediatric Oncology
FUTURE
Assistance Publique Hopitaux De Marseille
Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia
Assiut University
RAT-HEMATO
University Hospital, Angers
KCAT19
University College, London